177 related articles for article (PubMed ID: 6988274)
1. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD
Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274
[TBL] [Abstract][Full Text] [Related]
2. Circulating antibodies in diabetics treated with conventional and purified insulins.
Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
[TBL] [Abstract][Full Text] [Related]
3. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
[TBL] [Abstract][Full Text] [Related]
4. Insulin, pancreatic polypeptide, and glucagon antibodies in insulin-dependent diabetes mellitus.
Asplin CM; Hollander P; Pecoraro RE; Brodsky J; Palmer JP
Diabetes Care; 1981; 4(3):337-42. PubMed ID: 7047110
[TBL] [Abstract][Full Text] [Related]
5. Effects of species of origin, purification levels, and formulation on insulin immunogenicity.
Fineberg SE; Galloway JA; Fineberg NS; Goldman J
Diabetes; 1983 Jul; 32(7):592-9. PubMed ID: 6345238
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to insulin, pancreatic polypeptide, glucagon, and somatostatin in insulin-treated diabetics.
Fitz-Patrick D; Patel YC
J Clin Endocrinol Metab; 1981 May; 52(5):948-52. PubMed ID: 6112233
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to pancreatic hormones in diabetics treated before 1964 and after 1974.
Meryn S; Spigland I; Bauman WA
Clin Immunol Immunopathol; 1986 Aug; 40(2):291-7. PubMed ID: 2872983
[TBL] [Abstract][Full Text] [Related]
8. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity in diabetics induced by hormonal contaminants of insulin.
Bloom SR; Adrian TE; Barnes AJ; Polak JM
Lancet; 1979 Jan; 1(8106):14-7. PubMed ID: 83463
[TBL] [Abstract][Full Text] [Related]
10. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
[TBL] [Abstract][Full Text] [Related]
11. Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.
Czyzyk A; Rogala H; Lawecki J
Acta Diabetol Lat; 1989; 26(1):17-26. PubMed ID: 2665407
[TBL] [Abstract][Full Text] [Related]
12. [Determination of insulin, porcine proinsulin and pancreatic polypeptide antibodies in human serum by radioimmunoassay].
Deng SP; Zhou WB; Xiong ZY
Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):194-8. PubMed ID: 3549531
[No Abstract] [Full Text] [Related]
13. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
Bruni B; Gamba S; Regis G; Turco GL
Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
[TBL] [Abstract][Full Text] [Related]
14. [The preparation of highly purified insulin and its clinical use. Insulin Cooperative Study Group].
Yang J; Fang F; Zhu X; Deng S; Zhou W; Xing Z
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):178-80. PubMed ID: 1786955
[TBL] [Abstract][Full Text] [Related]
15. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
[TBL] [Abstract][Full Text] [Related]
16. Insulin allergy: reaginic antibodies to insulin and proinsulin.
Kumar D; Rosenquist RJ; Parameswaran V
J Clin Endocrinol Metab; 1979 Aug; 49(2):252-4. PubMed ID: 457844
[TBL] [Abstract][Full Text] [Related]
17. [Anti-insulin, proinsulin, pancreatic polypeptide, glucagon and somatostatin antibodies in patients with insulin-dependent diabetes mellitus treated with conventional insulin preparations].
Dominiak K; Gembal M; Horoszek-Maziarz S; Wójcikowski C
Endokrynol Pol; 1987; 38(4):281-90. PubMed ID: 2900755
[No Abstract] [Full Text] [Related]
18. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
[No Abstract] [Full Text] [Related]
19. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
Yue DK; Turtle JR
Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
[TBL] [Abstract][Full Text] [Related]
20. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
